CXCL12 is associated with FoxP3+ tumor‑infiltrating lymphocytes and affects the survival of patients with oral squamous cell carcinoma

Zhang,Bowen; Wu,Chenzhou; Zhang,Zhuoyuan; Yan,Kaixiao; Li,Chunjie; Li,Yi; Li,Longjiang

doi:10.3892/ol.2019.10415

CXCL12 is associated with FoxP3+ tumor‑infiltrating lymphocytes and affects the survival of patients with oral squamous cell carcinoma

Authors:
- Bowen Zhang
- Chenzhou Wu
- Zhuoyuan Zhang
- Kaixiao Yan
- Chunjie Li
- Yi Li
- Longjiang Li
View Affiliations

Affiliations: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: May 30, 2019 https://doi.org/10.3892/ol.2019.10415
Pages: 1099-1106
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The role of tumor‑infiltrating lymphocytes (TILs) suggests that cancer is a disease with not only a genetic, but also an immunological basis. Additionally, immune cell infiltration is an important feature of oral cancer. C‑X‑C motif chemokine ligand 12 (CXCL12) serves an important role in immune suppression in the tumor microenvironment. Therefore, the present study investigated how CXCL12 expression in oral squamous cell carcinoma (OSCC) was associated with clinicopathological parameters and TILs distribution. Complete CXCL12, TIL and clinical data were available for 45 patients with oral cancer treated by surgery. Expression levels of CXCL12, CD8+ TILs and forkhead box P3 (FoxP3+) TILs were assessed by immunohistochemistry in OSCC samples. CXCL12 expression in OSCC cells was observed in 32 (68.9%) cases and was associated with poor differentiation (P=0.045), advanced stages (P<0.001), tumor recurrence (P=0.011), poor overall survival (P=0.0476) and a higher density of FoxP3+ TILs (P<0.001). The CD8+/FoxP3+ ratio was lower in patients with poor differentiation (P=0.034), advanced stage tumors (P=0.015) and tumor recurrence (P=0.002). In addition, the ratio of CD8+/FoxP3+ TILs was significantly associated with the 5‑year overall survival rate (P<0.001). The CD8+/FoxP3+ ratio was indicated to be a stronger prognostic indicator compared with the density of FoxP3+ TILs or CD8+ TILs. The present study identified an association between increased CXCL12 expression and FoxP3+ cell infiltration in OSCC. Targeting the CXCL12/C‑X‑C motif chemokine receptor 4 axis in OSCC may be employed as a novel strategy of tumor immunotherapy in the future.

View Figures

View References

1	McDowell JD: An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin North Am. 39:277–294. 2006. View Article : Google Scholar : PubMed/NCBI
2	Williams HK: Molecular pathogenesis of oral squamous carcinoma. Mol Pathol. 53:165–172. 2000. View Article : Google Scholar : PubMed/NCBI
3	Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, et al: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 350:1945–1952. 2004. View Article : Google Scholar : PubMed/NCBI
4	Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009. View Article : Google Scholar : PubMed/NCBI
5	Wolf GT, Chepeha DB, Bellile E, Nguyen A, Thomas D and McHugh J; University of Michigan Head and Neck SPORE Program, : Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: A preliminary study. Oral Oncol. 51:90–95. 2015. View Article : Google Scholar : PubMed/NCBI
6	Watanabe Y, Katou F, Ohtani H, Nakayama T, Yoshie O and Hashimoto K: Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 109:744–752. 2010. View Article : Google Scholar : PubMed/NCBI
7	Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW, Melief CJ, Kenter GG, Fleuren GJ, Offringa R and van der Burg SH: High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res. 67:354–361. 2007. View Article : Google Scholar : PubMed/NCBI
8	Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E and Marth C: The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res. 11:8326–8331. 2005. View Article : Google Scholar : PubMed/NCBI
9	Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, et al: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 102:18538–18543. 2005. View Article : Google Scholar : PubMed/NCBI
10	Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW and Tang ZY: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 25:2586–2593. 2007. View Article : Google Scholar : PubMed/NCBI
11	Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG, van der Burg SH and Fleuren GJ: Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: Which variable determines survival of cervical cancer patients? Clin Cancer Res. 14:2028–2035. 2008. View Article : Google Scholar : PubMed/NCBI
12	Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, et al: CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 65:465–472. 2005.PubMed/NCBI
13	Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005. View Article : Google Scholar : PubMed/NCBI
14	Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
15	Xia J, Chen N, Hong Y, Chen X, Tao X, Cheng B and Huang Y: Expressions of CXCL12/CXCR4 in oral premalignant and malignant lesions. Mediators Inflamm. 2012:5163952012. View Article : Google Scholar : PubMed/NCBI
16	Liu F, Lang R, Zhao J, Zhang X, Pringle GA, Fan Y, Yin D, Gu F, Yao Z and Fu L: CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat. 130:645–655. 2011. View Article : Google Scholar : PubMed/NCBI
17	Rabinovich GA, Gabrilovich D and Sotomayor EM: Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 25:267–296. 2007. View Article : Google Scholar : PubMed/NCBI
18	Clatot F, Picquenot JM, Choussy O, Gouérant S, Moldovan C, Schultheis D, Cornic M, François A, Blot E and Laberge-Le-Couteulx S: Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma. Oral Oncol. 47:1062–1068. 2011. View Article : Google Scholar : PubMed/NCBI
19	Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT and Whiteside TL: A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res. 13:4345–4354. 2007. View Article : Google Scholar : PubMed/NCBI
20	Whiteside TL: The tumor microenvironment and its role in promoting tumor growth. Oncogene. 27:5904–5912. 2008. View Article : Google Scholar : PubMed/NCBI
21	Nguyen N, Bellile E, Thomas D, McHugh J, Rozek L, Virani S, Peterson L, Carey TE, Walline H, Moyer J, et al: Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck. 38:1074–1084. 2016. View Article : Google Scholar : PubMed/NCBI
22	Halama N, Michel S, Kloor M, Zoernig I, Benner A, Spille A, Pommerencke T, von Knebel DM, Folprecht G, Luber B, et al: Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. Cancer Res. 71:5670–5677. 2011. View Article : Google Scholar : PubMed/NCBI
23	Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, et al: Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res. 12:465–472. 2006. View Article : Google Scholar : PubMed/NCBI
24	Zou L, Barnett B, Safah H, Larussa VF, Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ and Zou W: Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64:8451–8455. 2004. View Article : Google Scholar : PubMed/NCBI
25	Obermajer N, Muthuswamy R, Odunsi K, Edwards RP and Kalinski P: PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res. 71:7463–7470. 2011. View Article : Google Scholar : PubMed/NCBI
26	Zboralski D, Hoehlig K, Eulberg D, Frömming A and Vater A: increasing tumor-infiltrating T cells through inhibition of CXCL12 with NOX-A12 synergizes with PD-1 blockade. Cancer Immunol Res. 5:950–956. 2017. View Article : Google Scholar : PubMed/NCBI